Despite these limitations, our data suggested that the prevalence of the polymorphisms PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs6834314 significantly differed between MASLD-HCC and VIRAL-HCC. Here, HSD17B13 is linked to hepatocellular carcinoma.